Angsterkrankungen und Therapieresistenz: Klinische Empfehlungen und Perspektiven
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
According to epidemiological studies, anxiety disorders are among the most frequent psychiatric disorders. In particular, nonresponse and treatment resistance represent a relevant challenge in daily clinical practice. However, prevalence and clinical management of treatment resistant anxiety disorders are far less investigated in comparison to treatment resistant major depression. Within the scope of this overview, studies on the treatment of therapy-resistant anxiety disorders are presented. The focus is on panic disorder, generalized anxiety disorder and social phobia. Potential treatment approaches include pharmacological approaches with atypical antipsychotics and anticonvulsants, combination therapies, the psychotherapeutic approach of acceptance and commitment therapy (ACT) and the experimental pharmacological use of D-cycloserine (DCS). The problem of pseudo-treatment-resistance, and the necessity of careful diagnostics and differential diagnostics are also discussed. © 2019 Georg Thieme Verlag. All rights reserved.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The size and burden of mental disorders and other disorders of the brain in Europe 2010
Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.018 · Cited by 3,754
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Treatment-resistant anxiety disorders
Bystritsky, A. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001852 · Cited by 289 · cited 2×
“Dennoch sprechen nach wie vor bis zu einem Drittel der Patienten nicht oder nicht ausreichend auf die Therapie an [6, 7].”
BackgroundBlanco, C., Heimberg, R. G., Schneier, F. R., Fresco, D. M., Chen, H., Turk, C. L., Vermes, D., Erwin, B. A., Schmidt, A. B., Juster, H. R., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.11 · Cited by 206 · cited 1×
“Blanco und Kollegen untersuchen die Effekte eines kombinierten pharmakologisch-psychotherapeutischen Vorgehens und zeigen, dass die Kombinationstherapie (KVT plus der MAO-Hemmer Phenelzin) einer Monotherapie deutlich überlegen ist [30].”
BackgroundPollack, M. H., Simon, N. M., Zalta, A. K., Worthington, J. J., Hoge, E. A., Mick, E. O., Kinrys, G., & Oppenheimer, J. E. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.005 · Cited by 146
Schoretsanitis, G., Paulzen, M., Unterecker, S., Schwarz, M., Conca, A., Zernig, G., Gründer, G., Haen, E., Baumann, P., Bergemann, N., et al. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2018.1439595 · Cited by 146
Pregabalin for the treatment of generalized anxiety disorder: an update
Baldwin, D., Ajel, Nowak, Rafiq, & Masdrakis, V. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s36453 · Cited by 125
Adjunctive Risperidone in Generalized Anxiety Disorder: A Double-Blind, Placebo-Controlled Study
Brawman-Mintzer, O., Knapp, R. G., & Nietert, P. J. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1016 · Cited by 124
Hofmann, S. G., Smits, J. A. J., Rosenfield, D., Simon, N., Otto, M. W., Meuret, A. E., Marques, L., Fang, A., Tart, C., & Pollack, M. H. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12070974 · Cited by 121 · cited 1×
“So zeigt beispielsweise eine Studie von Hofmann und Kollegen an 144 Patienten, dass eine Gabe von 50 mg D-Cycloserin eine Stunde vor der Expositionsbehandlung die klinische Symptomatik bei sozialer Angststörung im Vergleich zu Placebo signifikant verbessert [32].”
BackgroundSimon, N. M. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.s.7002.02 · Cited by 118 · cited 1×
“Dennoch sprechen nach wie vor bis zu einem Drittel der Patienten nicht oder nicht ausreichend auf die Therapie an [6, 7].”
BackgroundDoes D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis
Rodrigues, H., Figueira, I., Lopes, A., Gonçalves, R., Mendlowicz, M. V., Coutinho, E. S. F., & Ventura, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093519 · Cited by 109 · cited 1×
“Metaanalytische Auswertungen kommen zu unterschiedlichen Einschätzungen [33, 34] (▶Tab.”
BackgroundValproate treatment of panic disorder and lactate-induced panic attacks
Keck, P. E., Taylor, V. E., Tugrul, K. C., McElroy, S. L., & Bennett, J. A. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90010-b · Cited by 94
Stein, M. B., Sareen, J., Hami, S., & Chao, J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1725 · Cited by 91
Hirschmann, S., Dannon, P. N., Iancu, I., Dolberg, O. T., Zohar, J., & Grunhaus, L. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200010000-00011 · Cited by 89 · cited 1×
“Bei der Panikstörung wurde eine Augmentation mit Pindolol diskutiert [12], bei sozialer Phobie hatte diese Strategie offensichtlich keinen Erfolg [13].”
BackgroundGloster, A. T., Sonntag, R., Hoyer, J., Meyer, A. H., Heinze, S., Ströhle, A., Eifert, G., & Wittchen, H.-U. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000370162 · Cited by 88
Zwanzger, P., & Rupprecht, R. (2005) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0525 · Cited by 86
Self-citationPollack, M. H., Van Ameringen, M., Simon, N. M., Worthington, J. W., Hoge, E. A., Keshaviah, A., & Stein, M. B. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12101353 · Cited by 76
Simon, N. M., Connor, K. M., LeBeau, R. T., Hoge, E. A., Worthington, J. J., Zhang, W., Davidson, J. R. T., & Pollack, M. H. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1087-x · Cited by 72
Rickels, K., Shiovitz, T. M., Ramey, T. S., Weaver, J. J., Knapp, L. E., & Miceli, J. J. (2012) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328350b133 · Cited by 70
Yoshinaga, N., Matsuki, S., Niitsu, T., Sato, Y., Tanaka, M., Ibuki, H., Takanashi, R., Ohshiro, K., Ohshima, F., Asano, K., et al. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000444221 · Cited by 60
(2014) · MADOC (University of Mannheim) · Cited by 56
Self-citationLalonde, C. D., & Van Lieshout, R. J. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31821b2b3f · Cited by 51
McGuire, J. F., Wu, M. S., Piacentini, J., McCracken, J. T., & Storch, E. A. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15r10334 · Cited by 51
Simon, N. M., Otto, M. W., Worthington, J. J., Hoge, E. A., Thompson, E. H., LeBeau, R. T., Moshier, S. J., Zalta, A. K., & Pollack, M. H. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04485blu · Cited by 45
A Literature Review of Quetiapine for Generalized Anxiety Disorder
Kreys, T. M., & Phan, S. V. (2015) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1529 · Cited by 26
Efficacy and safety of treatments for refractory generalized anxiety disorder: a systematic review
Samuel, M., Zimovetz, E. A., Gabriel, Z., & Beard, S. M. (2011) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328341bb4a · Cited by 25
Pharmakotherapie bei Angsterkrankungen
Zwanzger, P. (2016) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-0042-106764 · Cited by 21
Self-citationA controlled trial of quetiapine XR coadministration treatment of SSRI-resistant panic disorder
Goddard, A. W., Mahmud, W., Medlock, C. E., Shin, Y., & Shekhar, A. (2015) · Annals of General Psychiatry · doi:10.1186/s12991-015-0064-0 · Cited by 20
Die Bedeutung von GABAA-Rezeptoren für Pathophysiologie und Therapie der Panikstörung
Rupprecht, R., & Zwanzger, P. (2003) · Der Nervenarzt · doi:10.1007/s00115-002-1433-x · Cited by 20
Self-citationTreatment in Nonresponsive Patients With Social Anxiety: Back to the Future With Benzodiazepines
Roy‐Byrne, P. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13101304 · Cited by 16
The potential role of atypical antipsychotics in the treatment of panic disorder
Wang, H. R., Woo, Y. S., & Bahk, W. (2014) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2419 · Cited by 13
Chronische Depression – Epidemiologische Daten und therapeutische Möglichkeiten
Schüle, C. (2014) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-0034-1366027 · Cited by 6
Cited by
Nichtansprechen auf Psychotherapie: Konzepte, Problemstellungen, Zuweisungsoptionen
Hoyer, J., & Plag, J. (2024) · Der Nervenarzt · doi:10.1007/s00115-024-01633-5 · Cited by 3
Angststörungen — Diagnostik, Psycho- und Pharmakotherapie
Volz, H., & Stieglitz, R. (2019) · DNP - Der Neurologe und Psychiater · doi:10.1007/s15202-019-2301-x · Cited by 3
Metadata
- Authors
- Zwanzger, P., & Diemer, J.
- Corresponding author
- Zwanzger, Peter
- Venue
- Nervenheilkunde
- Publisher
- Georg Thieme Verlag KG
- Published
- 2019-07
- Volume
- 38
- Issue
- 08
- Pages
- 565-569
- ISSN
- 0722-1541 (ISSN-L)
- 2567-5788
- OpenAlex
- W2965904078
- Cited by
- 2
- References
- 32
- Citations by year
- 2024: 1 · 2019: 1
- FWCI
- 0.29
- Type
- journal article
- Language
- de
- Open access
- closed
- Locations
- Nervenheilkunde (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- panic disorder, generalized anxiety disorder, social anxiety disorder, atypical antipsychotics, antiepileptic drugs, combination therapy, acceptance and commitment therapy, D-cycloserine, differential diagnosis, pharmacological treatment of anxiety
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.